Papa succeeds Miller as Emergent’s CEO

Emergent BioSolutions Inc. (NYSE:EBS) named Joseph Papa as president and CEO, succeeding Haywood Miller who is stepping down as interim CEO. Papa was CEO and chairman at Bausch + Lomb Corp. (NYSE:BLCO) where he led the company’s 2022 IPO. Emergent, which makes the opioid overdose treatment Narcan naloxone and medical countermeasures against infectious diseases, said Papa will oversea an era of “returning to growth” at the company.

Paratus Sciences Corp., which is leveraging bat biology to treat human inflammatory and metabolic diseases, named Theresa Heah as CEO. Heah was president and CEO of Intergalactic Therapeutics Inc...